.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Fish and Richardson
Colorcon
QuintilesIMS
Novartis
Accenture
Dow
McKesson
Johnson and Johnson
Mallinckrodt

Generated: September 26, 2017

DrugPatentWatch Database Preview

Pharmacia And Upjohn Company Profile

« Back to Dashboard

What is the competitive landscape for PHARMACIA AND UPJOHN, and what generic alternatives to PHARMACIA AND UPJOHN drugs are available?

PHARMACIA AND UPJOHN has one hundred and thirty-six approved drugs.

There are nine US patents protecting PHARMACIA AND UPJOHN drugs.

There are two hundred and eleven patent family members on PHARMACIA AND UPJOHN drugs in forty-six countries.

Summary for Applicant: Pharmacia And Upjohn

Patents:9
Tradenames:110
Ingredients:85
NDAs:136
Drug Master File Entries: (click here to view)41
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
MEDROL
methylprednisolone acetate
ENEMA;RECTAL018102-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
SOLU-MEDROL
methylprednisolone sodium succinate
INJECTABLE;INJECTION011856-005Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
HALCION
triazolam
TABLET;ORAL017892-001Nov 15, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-001Jan 17, 2003ABRXYesNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
HEPARIN SODIUM
heparin sodium
INJECTABLE;INJECTION004570-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
PREPIDIL
dinoprostone
GEL;ENDOCERVICAL019617-001Dec 9, 1992RXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
R-GENE 10
arginine hydrochloride
INJECTABLE;INJECTION016931-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
ZYVOX
linezolid
TABLET;ORAL021130-001Apr 18, 2000DISCNYesNo► Subscribe► SubscribeY► Subscribe
Pharmacia And Upjohn
XANAX XR
alprazolam
TABLET, EXTENDED RELEASE;ORAL021434-002Jan 17, 2003ABRXYesNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
MYCIFRADIN
neomycin sulfate
TABLET;ORAL060520-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Pharmacia And Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
XANAX
alprazolam
TABLET;ORAL018276-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pharmacia And Upjohn
ZYVOX
linezolid
TABLET;ORAL021130-001Apr 18, 2000► Subscribe► Subscribe
Pharmacia And Upjohn
GENOTROPIN PRESERVATIVE FREE
somatropin recombinant
INJECTABLE;INJECTION020280-012Jan 27, 1998► Subscribe► Subscribe
Pharmacia And Upjohn
ESTRING
estradiol
INSERT, EXTENDED RELEASE;VAGINAL020472-001Apr 26, 1996► Subscribe► Subscribe
Pharmacia And Upjohn
ESTRING
estradiol
INSERT, EXTENDED RELEASE;VAGINAL020472-001Apr 26, 1996► Subscribe► Subscribe
Pharmacia And Upjohn
GENOTROPIN PRESERVATIVE FREE
somatropin recombinant
INJECTABLE;INJECTION020280-005Jan 27, 1998► Subscribe► Subscribe
Pharmacia And Upjohn
GENOTROPIN PRESERVATIVE FREE
somatropin recombinant
INJECTABLE;INJECTION020280-001Jan 27, 1998► Subscribe► Subscribe
Pharmacia And Upjohn
XALATAN
latanoprost
SOLUTION/DROPS;OPHTHALMIC020597-001Jun 5, 1996► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-002Mar 25, 1998► Subscribe► Subscribe
Pharmacia And Upjohn
XANAX
alprazolam
TABLET;ORAL018276-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for PHARMACIA AND UPJOHN drugs

Drugname Dosage Strength Tradename Submissiondate
linezolid
Injection2 mg/mL, 100 mL bag
ZYVOX
12/29/2009
linezolid
Injection2 mg/mL, 300 mL bag
ZYVOX
9/1/2009
linezolid
Oral Suspension100 mg/5 mL
ZYVOX
8/3/2009
tolterodine tartrate
Extended-release Capsules2 mg and 4 mg
DETROL LA
7/30/2007
linezolid
Tablets600 mg
ZYVOX
12/21/2005
colestipol hydrochloride
Tablets1 g
COLESTID
8/23/2005

Non-Orange Book Patents for Pharmacia And Upjohn

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,780,613 Growth hormone variants► Subscribe
6,022,711 Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1► Subscribe
5,534,617 Human growth hormone variants having greater affinity for human growth hormone receptor at site 1► Subscribe
5,834,598 Human growth hormone variants► Subscribe
5,846,765 Identification of novel substrates► Subscribe
5,834,250 Method for identifying active domains and amino acid residues in polypeptides and hormone variants► Subscribe
5,750,373 Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants► Subscribe
6,428,954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants► Subscribe
5,688,666 Growth hormone variants with altered binding properties► Subscribe
8,637,646Growth hormone variants► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Pharmacia And Upjohn Drugs

Country Document Number Estimated Expiration
Australia718439► Subscribe
Spain2281142► Subscribe
Eurasian Patent Organization200201006► Subscribe
Spain2113940► Subscribe
Austria354390► Subscribe
Hong Kong1032920► Subscribe
Greece3026468► Subscribe
MexicoPA00005214► Subscribe
Japan2005065705► Subscribe
TaiwanI293028► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Pharmacia And Upjohn Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0046Belgium► SubscribePRODUCT NAME: DOXORUBICIN HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/96/011/001 19960624
2009004,C0770388Lithuania► SubscribePRODUCT NAME: ESTRADIOLI VALERAS + DIENOGESTUM; NAT. REGISTRATION NO/DATE: LT/1/09/1512/001, 2009 04 06 LT/1/09/1512/002, 2009 04 06 LT/1/09/1512/003 20090406; FIRST REGISTRATION: BE 327792 20081103
C0018France► SubscribePRODUCT NAME: ESTRADIOL VALERATE; DIENOGEST; NAT. REGISTRATION NO/DATE: NL35170 20081210; FIRST REGISTRATION: BE327792 20081103
80020Netherlands► SubscribePRODUCT NAME: TOLTERODINE, DESGEWENST IN DE VORM VAN EEN ZOUT MET EEN FYSIOLO GISCH ACCEPTABEL ZUUR, IN HET BIJZONDER TOLTERODINE L-TARTRAAT; NAT. REGISTRATION NO/DATE: RVG 22148, RVG 22149 19980217; FIRST REGISTRATION: SE 13475, 13476 19970905
C/GB97/003United Kingdom► SubscribePRODUCT NAME: IBUTILIDE, OR A PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF, ESPECIALLY IBUTILIDE FUMARATE; REGISTERED: UK 00032/0212 19960930
/1997Austria► SubscribePRODUCT NAME: LATANOPROST UND SEINE THERAPEUTISCH AKTIVEN UND PHYSIOLOGISCH ANNEHMBAREN DERIVATE; NAT. REGISTRATION NO/DATE: 1-22019 19970627; FIRST REGISTRATION: SE 12716 19960718
C/GB09/026United Kingdom► SubscribePRODUCT NAME: ESTRADIOL AND COMBINATIONS OF ESTRADIOL AND DIENOGEST, PREFERABLY ESTRADIOL VALERATE AND COMBINATIONS OF ESTRADIOL VALERATE AND DIENOGEST; REGISTERED: BE BE 327792 20081103; UK PL 00010/0576-0001 20081208
C/GB97/014United Kingdom► SubscribePRODUCT NAME: LATANOPROST (I.E. 13,14-DIHYDRO-17-PHENYL-18,19,20-TRINOR-PGF-ALPHA-ISOPROPYLESTER); NAT. REGISTRATION NO/DATE: 00032/0220 19961216; FIRST REGISTRATION: SE 12716 19960718; SPC EXTENSION AUTHORISATION: PL00057/1057-008 20101216
2009 00017Denmark► SubscribePRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629
2013025,C1304992Lithuania► SubscribePRODUCT NAME: CLINDAMYCINUM + TRETINOINUM; REGISTRATION NO/DATE: LT/1/13/3279/001, 2013 04 26 LT/1/13/3279/002, 2013 04 26 PA1332/043/001 20130323
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Argus Health
Chubb
US Department of Justice
Cantor Fitzgerald
Chinese Patent Office
Queensland Health
Merck
Fuji
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot